Delivery Order SPE2DP25D0002-SPE2DP26F1506
- Not listed
- Valneva USA, Inc., a specialty vaccine manufacturer headquartered in Bethesda, Maryland and subsidiary of French-based Valneva SE, was awarded a delivery order valued at $8.25 million on October 23, 2025, for Japanese encephalitis vaccine (IXIARO) to support the Medical Supply Chain program within the Defense Department. This firm fixed-price delivery order, with an ultimate completion date of December 5, 2025, represents performance at Valneva USA's Bethesda facility and carries no set-aside...
- This is a $16,016,000.00 firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is for the supply of the Japanese encephalitis vaccine IXIARO. This delivery order is part of a larger $48,025,600 indefinite delivery contract awarded to Valneva USA in September 2023, which supports the Department of Defense's medical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $14,201,021.80 firm-fixed-price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is for the delivery of the Japanese encephalitis vaccine IXIARO to support the Department of Defense's medical countermeasures program. This delivery order is part of two larger Indefinite Delivery Contracts (IDCs) awarded to Valneva...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the specialty vaccine company Valneva SE. The $12,790,400.00 contract is for the delivery of the Japanese encephalitis vaccine IXIARO, with a completion date of March 13, 2024. This award is likely associated with Valneva USA's existing Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with the Defense...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract (SPE2DP23D0004) to Valneva USA, Inc., doing business as Intercell USA Inc., for the supply of the Japanese encephalitis vaccine IXIARO. The contract has a ceiling value of $3,203,200.00 and a completion date of June 5, 2024. This order is part of a larger $48,025,600 indefinite-delivery/indefinite-quantity (IDIQ) contract awarded to Valneva USA in 2023, which supports the Department...
- This federal contract award, valued at $10,638,400.00, was issued by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a specialty vaccine company, for the supply of the Japanese encephalitis vaccine IXIARO. The contract is a firm fixed price delivery order with a period of performance through September 30, 2024. Valneva USA, a subsidiary of the France-based Valneva SE, is the prime contractor and holds several other significant...
- The Department of Veterans Affairs, Veterans Integrated Service Network 12, awarded a delivery order valued at $769,125.84 to Valneva USA, Inc. (doing business as Intercell USA Inc.) on October 1, 2024, for the supply of Japanese encephalitis virus vaccine (IXIARO). This firm fixed-price delivery order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carries an ultimate completion date of September 30, 2025. The contract includes no set-aside designation....
- This is a firm fixed-price delivery order contract awarded to Valneva USA, Inc., a subsidiary of the French vaccine company Valneva SE, by the Medical Supply Chain division of the U.S. Department of Defense. The $5,883,494.40 contract is for the provision of the Japanese encephalitis vaccine IXIARO, with a period of performance ending on July 31, 2025. Valneva USA, Inc. serves as the prime contractor and is responsible for vaccine production and delivery, primarily from its Potomac, Maryland...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc., doing business as Intercell USA Inc. The contract is for the provision of the Japanese encephalitis vaccine IXIARO, with a potential value of $3,203,200.00 and a completion date of January 19, 2024. Valneva USA, a subsidiary of the specialty vaccine company Valneva SE, has received numerous prime federal contract awards, primarily from the Defense Logistics...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Valneva USA, Inc. (a subsidiary of the French vaccine company Valneva SE) to supply the Japanese encephalitis vaccine IXIARO. The contract has a ceiling value of $48,000.00 and a completion date of December 31, 2025. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $48,025,600, to support the Department of Defense's medical countermeasures...
- SPE2DP25D0002Indefinite Delivery Contract
- SPE2DP25D0002-SPE2DP26F1506Delivery Order
The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $4.41 million to Valneva USA, Inc. (doing business as Intercell USA Inc.) on January 7, 2026, for Japanese encephalitis vaccine (IXIARO), with final delivery expected by February 26, 2026. The contract carries firm fixed-price terms with no set-aside designation. Valneva USA, a Bethesda, Maryland-based subsidiary of French-based Valneva SE, is the sole prime contractor on this delivery order, which will be performed at the company's Bethesda facility. This delivery order represents a task order issued under one of three significant indefinite delivery vehicles that Valneva USA maintains with the Defense Logistics Agency Troop Support Medical, the Veterans Affairs system, and the Department of Defense. This award supports critical military medical readiness and federal personnel health protection initiatives through the procurement of Japanese encephalitis vaccine. Valneva USA has established itself as the primary federal supplier of IXIARO vaccine, with extensive contract history across multiple federal agencies including the Defense Logistics Agency, Veterans Affairs, Department of State, Department of Health and Human Services, and the Federal Bureau of Investigation. The company's largest underlying indefinite delivery contract—a single-award vehicle worth $49.3 million with the Defense Logistics Agency awarded in January 2025—provides the framework for this and related delivery orders supporting Department of Defense medical countermeasures requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4m | 1/6/26 |